Innovative NeuroTechnologies
Pre-clinicalInnovative NeuroTechnologies, Inc. (INT) is a development-stage biotechnology company operating in a “virtual mode” that is pursuing novel biologically-based and disease-modifying therapeutic solutions for a spectrum of neurodegenerative disorders referred to as tauopathies. Dysregulation of the Tau protein is the result of some genetic diseases that currently have no effective treatments, and is largely responsible for the onset of Alzheimer’s disease (AD). By focusing on Tau, we are develop...
Private Company
Funding information not available
About
Innovative NeuroTechnologies, Inc. (INT) is a development-stage biotechnology company operating in a “virtual mode” that is pursuing novel biologically-based and disease-modifying therapeutic solutions for a spectrum of neurodegenerative disorders referred to as tauopathies. Dysregulation of the Tau protein is the result of some genetic diseases that currently have no effective treatments, and is largely responsible for the onset of Alzheimer’s disease (AD). By focusing on Tau, we are develop...